


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 4 Jan 2024
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect(TM)
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect(TM)
HSMN NewsFeed - 15 Dec 2023
CymaBay Submits New Drug Application to FDA for Seladelpar for the Treatment of Primary Biliary Cholangitis
CymaBay Submits New Drug Application to FDA for Seladelpar for the Treatment of Primary Biliary Cholangitis
HSMN NewsFeed - 14 Dec 2023
Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb
Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb
HSMN NewsFeed - 13 Dec 2023
Triveni Bio Welcomes Jeff Albers and Allison Luo to its Board of Directors
Triveni Bio Welcomes Jeff Albers and Allison Luo to its Board of Directors
HSMN NewsFeed - 29 Nov 2023
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
HSMN NewsFeed - 20 Nov 2023
FDA Grants Orphan Drug Designation to NeoImmuneTech's NT-I7 for the Treatment of Acute Radiation Syndrome
FDA Grants Orphan Drug Designation to NeoImmuneTech's NT-I7 for the Treatment of Acute Radiation Syndrome
HSMN NewsFeed - 17 Nov 2023
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
